Citigroup’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Citigroup’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-287,344	Closed	-$9.88M	–	7774
2014 Q4	$9.88M	Buy	287,344 +274,414	+2,122%	+$8.95M	0.01%	1284
2014 Q3	$386K	Buy	12,930 +6,807	+111%	+$144K	﹤0.01%	3727
2014 Q2	$123K	Sell	6,123 -25,734	-81%	-$590K	﹤0.01%	4524
2014 Q1	$865K	Sell	31,857 -4,078	-11%	-$108K	﹤0.01%	2989
2013 Q4	$745K	Buy	35,935 +5,614	+19%	+$106K	﹤0.01%	3461
2013 Q3	$552K	Buy	30,321 +8,664	+40%	+$157K	﹤0.01%	3360
2013 Q2	$361K	Buy	+21,657	New	+$346K	﹤0.01%	3771

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Citigroup's AUXL Position: Q1 2015 in Review

Citigroup sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 287,344 shares — an estimated $9.88M sold.

Citigroup first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $9.88M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

Citigroup reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Citigroup sold 287,344 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $9.88M.
Citigroup first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
Citigroup's AUXILIUM PHARAMCEUTICALS INC position peaked at $9.88M in Q4 2014.
1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Citigroup's 13F filing for Q1 2015, filed 14 May 2015.